1. Home
  2. CXM vs COLL Comparison

CXM vs COLL Comparison

Compare CXM & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$5.50

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$38.48

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXM
COLL
Founded
2009
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
CXM
COLL
Price
$5.50
$38.48
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$8.28
$51.40
AVG Volume (30 Days)
4.6M
440.9K
Earning Date
06-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
0.40
Revenue
$857,200,000.00
$780,567,000.00
Revenue This Year
$2.52
$8.01
Revenue Next Year
$4.94
N/A
P/E Ratio
$60.72
$97.73
Revenue Growth
7.64
23.62
52 Week Low
$4.72
$28.34
52 Week High
$9.40
$50.79

Technical Indicators

Market Signals
Indicator
CXM
COLL
Relative Strength Index (RSI) 52.59 70.40
Support Level $5.19 $34.29
Resistance Level $6.16 $39.85
Average True Range (ATR) 0.23 1.40
MACD 0.06 0.66
Stochastic Oscillator 88.35 88.46

Price Performance

Historical Comparison
CXM
COLL

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: